{
  "meta": {
    "id": "test50",
    "title": "Pancreas (Pancreatic Neoplasm)",
    "category": "Subject Wise / Mixed"
  },
  "questions": [
    {
      "text": "A 70-year-old man is brought to the physician by his son because of gradually progressive yellow discoloration of his skin and generalized pruritus for the past 2 weeks. During this period, his appetite has decreased and he has had a 6.5-kg weight loss. He reports that his stool appears pale and his urine is very dark. Three years ago, he had an episode of acute upper abdominal pain that was treated with IV fluids, NSAIDs, and dietary modification. He has stopped drinking alcohol since then; he used to drink 1\u20132 beers daily for 40 years. He has smoked a pack of cigarettes daily for the past 50 years. His vital signs are within normal limits. Physical examination shows yellowing of the conjunctivae and skin. The abdomen is soft and non-tender; a soft, cystic mass is palpated in the right upper quadrant. Serum studies show Abdominal ultrasonography shows an anechoic cystic mass in the subhepatic region and dilation of the intrahepatic and extrahepatic bile ducts. Which of the following is the most likely diagnosis?",
      "options": [
        {
          "label": "A",
          "text": "Pancreatic Adenocarcinoma",
          "correct": true
        },
        {
          "label": "B",
          "text": "Acute cholangitis",
          "correct": false
        },
        {
          "label": "C",
          "text": "Choledocholithiasis",
          "correct": false
        },
        {
          "label": "D",
          "text": "Alcoholic hepatitis",
          "correct": false
        }
      ],
      "correct_answer": "A. Pancreatic Adenocarcinoma",
      "question_images": [
        "https://dbmi-data.s3.ap-south-1.amazonaws.com/questionImage-1694252274758-QTDS051001IMG1.JPG"
      ],
      "explanation_images": [],
      "explanation": "<p><strong>Solution:</strong></p><p>Pancreatic Adenocarcinoma This patient presents with painless jaundice, anorexia, and unexplained weight loss. Investigations show conjugated hyperbilirubinemia, signs of extrahepatic biliary tract obstruction (dilated intra and extrahepatic bile ducts), and a distended non tender gall bladder (anechoic subhepatic cystic mass). These features, esp. in a person of advanced age with a history of smoking and alcohol consumption, are highly suggestive of a pancreatic adenocarcinoma located in the head of the pancreas, obstructing the distal common bile duct.</p>\n<p><strong>Highyeild:</strong></p><p>Carcinoma Pancreas is a type of cancer that originates in the pancreas, with the most common type being pancreatic ductal adenocarcinoma (PDAC). The majority of PDAC cases occur in the head of the pancreas, with a smaller percentage occurring in the body and tail. Management: More than 85% of patients with ductal adenocarcinoma have advanced disease and are not suitable for resection. If imaging shows a potentially resectable tumor , surgical resection should be considered as it offers the only chance of a cure, albeit a small one. For patients with locally advanced or metastatic disease , the primary objective should be to relieve symptoms, improve quality of life, and extend survival, rather than achieving a cure. Patients with pancreatic cancer fall into four categories: resectable, borderline resectable, locally advanced and unresectable, and metastatic. Resectable patients should be offered surgery followed by adjuvant chemotherapy. Borderline resectable patients may be offered neoadjuvant chemotherapy with or without chemoradiotherapy, followed by surgical resection if the disease has been downstaged. Adjuvant therapy should follow. Locally advanced and unresectable patient s should be offered systemic chemotherapy , with surgery being a possibility in a small cohort who get downstaged. Metastatic patients should be offered systemic chemotherapy. If a cystic tumor is encountered, regardless of size, surgical resection should be considered as it carries a reasonable chance of cure. Tumors of the ampulla have a good prognosis and should be resected if possible, as should some rare tumors and neuroendocrine lesions.</p>\n<p><strong>Random:</strong></p><p>Explanation for incorrect options: - Option: B. Acute cholangitis typically presents with right upper abdominal pain, fever, and, less commonly, obstructive jaundice (Charcot's triad). Patients are usually acutely ill, with tachycardia and right upper abdominal guarding and tenderness. Unexplained weight loss, normal vital parameters, and a non tender cystic mass in the right quadrant are not features of acute cholangitis. Option: C. Choledocholithiasis typically presents with colicky right upper abdominal pain, nausea, vomiting, fever, and obstructive jaundice. Acute obstruction of the common bile duct could result in painful enlargement of the gallbladder. In the case of chronic choledocholithiasis, the gallbladder is usually fibrotic, small, and impalpable because of chronic irritation by gallstones. Furthermore, choledocholithiasis does not cause pronounced weight loss. Option: D. Alcoholic hepatitis presents with anorexia, weight loss, and jaundice in patients with chronic alcohol consumption. Patients with alcoholic hepatitis present with abdominal pain, tender hepatomegaly, and ascites; investigations would show a moderate elevation in AST and ALT as well as mixed hyperbilirubinemia. This patient has features of complete biliary outflow obstruction (conjugated hyperbilirubinemia, pale stools, dark urine), normal AST and ALT levels, and no evidence of hepatomegaly. Also, although this patient has a history of chronic alcohol consumption, he has been sober for 3 years, making alcoholic hepatitis an unlikely cause of his symptoms.</p>\n<p><strong>Extraedge:</strong></p><p>During an examination, physicians should look for signs of jaundice, weight loss, a palpable liver, and a palpable gallbladder. Courvoisier first noticed the association between an enlarged gallbladder and pancreatic tumors in 1890. Patients with a recent diabetes diagnosis and upper abdominal symptoms, especially those above 50 years of age with no family history or obesity, should be suspected of having pancreatic tumors. Unexplained pancreatitis may also be a sign of tumors and should be followed up with imaging.</p>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "c48e5955",
      "audio": ""
    },
    {
      "text": "A 67-year-old woman is referred with a 4-month history of weight loss and progressive jaundice. Her CA19-9 is raised and her ultrasound reveals dilated hepatic ducts. ERCP was attempted but was abandoned due to failure of passage of the scope beyond the distal common bile duct stricture. What is the next best investigation that can be done on this patient?",
      "options": [
        {
          "label": "A",
          "text": "Colonoscopy",
          "correct": false
        },
        {
          "label": "B",
          "text": "Contrast-enhanced CT",
          "correct": true
        },
        {
          "label": "C",
          "text": "ERCP",
          "correct": false
        },
        {
          "label": "D",
          "text": "Endoscopic ultrasound",
          "correct": false
        }
      ],
      "correct_answer": "B. Contrast-enhanced CT",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Solution:</strong></p><p>Contrast-enhanced CT The Patient\u2019s findings are suspicious of pancreatic head cancer so to confirm the diagnosis this is done. It also tells whether the tumor is resectable or not presence of hepatic or peritoneal lymph node metastasis.</p>\n<p><strong>Highyeild:</strong></p><p>Carcinoma Pancreas is a type of cancer that originates in the pancreas, with the most common type being pancreatic ductal adenocarcinoma (PDAC). The majority of PDAC cases occur in the head of the pancreas, with a smaller percentage occurring in the body and tail. Management: More than 85% of patients with ductal adenocarcinoma have advanced disease and are not suitable for resection. If imaging shows a potentially resectable tumor , surgical resection should be considered as it offers the only chance of a cure, albeit a small one. For patients with locally advanced or metastatic disease , the primary objective should be to relieve symptoms, improve quality of life, and extend survival, rather than achieving a cure. Patients with pancreatic cancer fall into four categories: resectable, borderline resectable, locally advanced and unresectable, and metastatic. Resectable patients should be offered surgery followed by adjuvant chemotherapy. Borderline resectable patients may be offered neoadjuvant chemotherapy with or without chemoradiotherapy, followed by surgical resection if the disease has been downstaged. Adjuvant therapy should follow. Locally advanced and unresectable patient s should be offered systemic chemotherapy , with surgery being a possibility in a small cohort who get downstaged. Metastatic patients should be offered systemic chemotherapy. If a cystic tumor is encountered, regardless of size, surgical resection should be considered as it carries a reasonable chance of cure. Tumors of the ampulla have a good prognosis and should be resected if possible, as should some rare tumors and neuroendocrine lesions.</p>\n<p><strong>Random:</strong></p><p>Explanation for incorrect options: - Option: A. Colonoscopy is used for diagnosis of colon cancer. Option: C. ERCP is invasive and can't define the extent of the tumor. Option: D. EUS is useful if CT fails to demonstrate tumor if tissue diagnosis is required prior to surgery.</p>\n<p><strong>Extraedge:</strong></p><p>During an examination, physicians should look for signs of jaundice, weight loss, a palpable liver, and a palpable gallbladder. Courvoisier first noticed the association between an enlarged gallbladder and pancreatic tumors in 1890. Patients with a recent diabetes diagnosis and upper abdominal symptoms, especially those above 50 years of age with no family history or obesity, should be suspected of having pancreatic tumors. Unexplained pancreatitis may also be a sign of tumors and should be followed up with imaging.</p>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "ebe14ec0",
      "audio": ""
    },
    {
      "text": "A 65-year-old woman presents to her physician with general malaise and grumbling abdominal pain. Her daughter thinks she is looking a little yellow. Her physician refers her for a specialist opinion and on examination there is a mass in the right upper quadrant. Select the likely diagnosis:",
      "options": [
        {
          "label": "A",
          "text": "Carcinoma of the head of the pancreas",
          "correct": true
        },
        {
          "label": "B",
          "text": "Acute pancreatitis",
          "correct": false
        },
        {
          "label": "C",
          "text": "Pancreatic pseudocyst",
          "correct": false
        },
        {
          "label": "D",
          "text": "Cholelithiasis",
          "correct": false
        }
      ],
      "correct_answer": "A. Carcinoma of the head of the pancreas",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Solution:</strong></p><p>Carcinoma of the head of the pancreas</p>\n<p><strong>Highyeild:</strong></p><p>Carcinoma Pancreas is a type of cancer that originates in the pancreas, with the most common type being pancreatic ductal adenocarcinoma (PDAC). The majority of PDAC cases occur in the head of the pancreas, with a smaller percentage occurring in the body and tail. Management: More than 85% of patients with ductal adenocarcinoma have advanced disease and are not suitable for resection. If imaging shows a potentially resectable tumor , surgical resection should be considered as it offers the only chance of a cure, albeit a small one. For patients with locally advanced or metastatic disease , the primary objective should be to relieve symptoms, improve quality of life, and extend survival, rather than achieving a cure. Patients with pancreatic cancer fall into four categories: resectable, borderline resectable, locally advanced and unresectable, and metastatic. Resectable patients should be offered surgery followed by adjuvant chemotherapy. Borderline resectable patients may be offered neoadjuvant chemotherapy with or without chemoradiotherapy, followed by surgical resection if the disease has been downstaged. Adjuvant therapy should follow. Locally advanced and unresectable patient s should be offered systemic chemotherapy , with surgery being a possibility in a small cohort who get downstaged. Metastatic patients should be offered systemic chemotherapy. If a cystic tumor is encountered, regardless of size, surgical resection should be considered as it carries a reasonable chance of cure. Tumors of the ampulla have a good prognosis and should be resected if possible, as should some rare tumors and neuroendocrine lesions.</p>\n<p><strong>Random:</strong></p><p>Explanation for incorrect options: - Option: B. Acute pancreatitis - The common presentations include central abdominal pain that starts at a low intensity and gradually increases in severity. The pain may radiate to the back, may be associated with nausea and vomiting, and may be improved by sitting forward. The gall bladder is non-palpable in cholelithiasis. Option: C. Pancreatic pseudocyst is defined as a localized collection of pancreatic secretions, usually rich in digestive enzymes, that is enclosed by the non-epithelialized wall. It takes four weeks or more from an attack of pancreatitis to form a pseudocyst. Option: D. Courvoisier\u2019s law states that a palpable gallbladder in the presence of jaundice is more likely to be a malignancy than gallstones. Jaundice secondary to obstruction of the distal bile duct is the most common symptom that draws attention to ampullary or pancreatic head tumors. It is characteristically painless jaundice but may be associated with Nausea or epigastric discomfort.</p>\n<p><strong>Extraedge:</strong></p><p>During an examination, physicians should look for signs of jaundice, weight loss, a palpable liver, and a palpable gallbladder. Courvoisier first noticed the association between an enlarged gallbladder and pancreatic tumors in 1890. Patients with a recent diabetes diagnosis and upper abdominal symptoms, especially those above 50 years of age with no family history or obesity, should be suspected of having pancreatic tumors. Unexplained pancreatitis may also be a sign of tumors and should be followed up with imaging.</p>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "5e770805",
      "audio": ""
    },
    {
      "text": "A 75-year-old lady from a residential home presents to the clinic with jaundice and weight loss. She also complains of pale, buoyant stools and dark urine. She denies any pain or vomiting. Clinical examination reveals conjunctival pallor, yellow sclera, and a non-tender, palpable mass in the right upper quadrant. Routine laboratory investigations reveal grossly elevated bilirubin and ALP levels, and mildly elevated GGT levels. What is the most likely diagnosis?",
      "options": [
        {
          "label": "A",
          "text": "Common bile duct stone",
          "correct": false
        },
        {
          "label": "B",
          "text": "Empyema",
          "correct": false
        },
        {
          "label": "C",
          "text": "Mucocele",
          "correct": false
        },
        {
          "label": "D",
          "text": "Carcinoma of the head of the pancreas",
          "correct": true
        }
      ],
      "correct_answer": "D. Carcinoma of the head of the pancreas",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Solution:</strong></p><p>Carcinoma of the head of the pancreas Courvoisier's law states that, in the presence of jaundice, an enlarged gallbladder is unlikely to be due to gallstones. In such cases, carcinoma of the pancreas or of the lower biliary tree is more likely . Gallstones form over a longer period of time, causing chronic irritation, fibrotic thickening, and a shrunken gallbladder. In this scenario, given the history of weight loss, carcinoma of the pancreatic head is the most likely cause.</p>\n<p><strong>Highyeild:</strong></p><p>Carcinoma Pancreas is a type of cancer that originates in the pancreas, with the most common type being pancreatic ductal adenocarcinoma (PDAC). The majority of PDAC cases occur in the head of the pancreas, with a smaller percentage occurring in the body and tail. Management: More than 85% of patients with ductal adenocarcinoma have advanced disease and are not suitable for resection. If imaging shows a potentially resectable tumor , surgical resection should be considered as it offers the only chance of a cure, albeit a small one. For patients with locally advanced or metastatic disease , the primary objective should be to relieve symptoms, improve quality of life, and extend survival, rather than achieving a cure. Patients with pancreatic cancer fall into four categories: resectable, borderline resectable, locally advanced and unresectable, and metastatic. Resectable patients should be offered surgery followed by adjuvant chemotherapy. Borderline resectable patients may be offered neoadjuvant chemotherapy with or without chemoradiotherapy, followed by surgical resection if the disease has been downstaged. Adjuvant therapy should follow. Locally advanced and unresectable patient s should be offered systemic chemotherapy , with surgery being a possibility in a small cohort who get downstaged. Metastatic patients should be offered systemic chemotherapy. If a cystic tumor is encountered, regardless of size, surgical resection should be considered as it carries a reasonable chance of cure. Tumors of the ampulla have a good prognosis and should be resected if possible, as should some rare tumors and neuroendocrine lesions.</p>\n<p><strong>Random:</strong></p><p>Explanation for incorrect options: - Option: A, B, and C. All other causes result in pain or tenderness within the right upper quadrant. If the gallbladder outflow tract is obstructed with a stone, the gallbladder becomes distended with mucus and is referred to as a mucocele, and is often palpable and tender. When its contents become infected, an abscess develops and is known as empyema.</p>\n<p><strong>Extraedge:</strong></p><p>During an examination, physicians should look for signs of jaundice, weight loss, a palpable liver, and a palpable gallbladder. Courvoisier first noticed the association between an enlarged gallbladder and pancreatic tumors in 1890. Patients with a recent diabetes diagnosis and upper abdominal symptoms, especially those above 50 years of age with no family history or obesity, should be suspected of having pancreatic tumors. Unexplained pancreatitis may also be a sign of tumors and should be followed up with imaging.</p>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "c39cdeaf",
      "audio": ""
    },
    {
      "text": "Which of the following is not true about gastrinomas?",
      "options": [
        {
          "label": "A",
          "text": "The majority of gastrinomas are located in the gastrinoma triangle",
          "correct": false
        },
        {
          "label": "B",
          "text": "25% of all gastrinomas are associated with MEN 2",
          "correct": true
        },
        {
          "label": "C",
          "text": "Calcium stimulation tests are used to differentiate gastrinomas from other causes of hypergastrinemia",
          "correct": false
        },
        {
          "label": "D",
          "text": "Gastrinomas associated with MEN are usually located in the duodenum",
          "correct": false
        }
      ],
      "correct_answer": "B. 25% of all gastrinomas are associated with MEN 2",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Solution:</strong></p><p>25% of all gastrinomas are associated with MEN 2 Gastrinomas are rare gastrin-secreting tumors of non-beta pancreatic islet cells. Most tumors are sporadic and are commonly found in the pancreas. About 25% are associated with MEN type 1 and tend to be found in the duodenum. Sporadic tumors have greater malignant potential. Overall, the majority of the tumors are located in the gastrinoma triangle, which is bounded superiorly by the cystic duct, inferiorly by the second and third parts of the duodenum, and medially by the head of the pancreas.</p>\n<p><strong>Highyeild:</strong></p><p>In 70-90% of patients, primary gastrinoma is found in Passaro's triangle, but whole-body imaging is required due to the possibility of gastrinomas appearing anywhere in the body. SSTR (octreotide) scintigraphy in combination with CT is the test of choice, and EUS can be helpful in localizing tumors in the pancreatic head or duodenal wall. MEN1 syndrome should be ruled out before surgery, and surgical treatment is justified in patients with sporadic gastrinomas. Approximately 50% of gastrinomas metastasize to lymph nodes or the liver, and patients who meet the criteria for operability should undergo exploration for possible removal of the tumor. Pancreatic tumors are usually larger than tumors arising in the duodenum, and more often they have lymph node metastases.</p>\n<p><strong>Random:</strong></p><p>Explanation for incorrect options: - Options A, C, and D: All other statements are true</p>\n<p><strong>Extraedge:</strong></p><p>Despite the lack of success in achieving a biochemical cure, long-term survival rates are good, even in patients with liver metastases. The best results are seen after the complete excision of small sporadic tumors originating in the duodenum, while large tumors associated with liver metastases located outside of Passaro's triangle have the worst prognosis.</p>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "52484f3a",
      "audio": ""
    },
    {
      "text": "A 52-year-old patient presents to his physician with a 4-week history of upper abdominal pain and diarrhea. He also describes a few episodes of \u2018dark-colored\u2019 vomitus during this period. The general examination is unremarkable. Esophagogastroduodenoscopy reveals multiple ulcers in the stomach and duodenum. What is the most likely diagnosis?",
      "options": [
        {
          "label": "A",
          "text": "Vasoactive intestinal peptide secreting tumor",
          "correct": false
        },
        {
          "label": "B",
          "text": "Insulinoma",
          "correct": false
        },
        {
          "label": "C",
          "text": "Somatostatinoma",
          "correct": false
        },
        {
          "label": "D",
          "text": "Gastrinoma",
          "correct": true
        }
      ],
      "correct_answer": "D. Gastrinoma",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Solution:</strong></p><p>Gastrinoma Gastrinomas primarily occur in the pancreas and duodenum and are malignant in nearly two-thirds of cases. The patients may present with upper abdominal pain and vomiting; the vomitus may be \u2018coffee-ground\u2019 due to the digestion of blood (from the ulcers) within the stomach. Gastrinomas may either arise sporadically or as part of Zollinger\u2013Ellison syndrome (i.e. peptic ulceration, gastric acid hypersecretion, and islet cell tumors of the pancreas). Sporadic Zollinger\u2013Ellison syndrome occurs most frequently in the fifth decade of life.</p>\n<p><strong>Highyeild:</strong></p><p>Zollinger-Ellison syndrome (ZES) is caused by gastrinoma , an endocrine tumor that secretes gastrin, leading to acid hypersecretion and peptic ulceration. Patients with ZES may present with abdominal pain, peptic ulcer disease, severe esophagitis, and diarrhea. In the era of effective antacid therapy, the presentation of ZES can be less dramatic, and multiple ulcers in atypical locations that fail to respond to antacids should raise suspicion for ZES. The diagnosis of ZES is made by measuring the serum gastrin level, but patients must stop taking proton pump inhibitors for accurate testing. Other conditions can cause elevated gastrin levels, including pernicious anemia, treatment with proton pump inhibitors, renal failure, G-cell hyperplasia, atrophic gastritis, retained or excluded antrum, and gastric outlet obstruction. In equivocal cases, a secretin stimulation test may be necessary to confirm the diagnosis of ZES.</p>\n<p><strong>Random:</strong></p><p>Explanation for incorrect options: - Option: A. The vasoactive intestinal peptide-secreting tumor ( VIPoma ) syndrome is also called the WDHA syndrome due to the presence of watery diarrhea, hypokalemia, and achlorhydria. Option: B. Insulinoma - patients can present with a profound syncopal episode or less severe symptoms that are averted by frequent eating. Common symptoms include palpitations, trembling, diaphoresis, confusion or obtundation, and seizure, and family members may report that the patient has undergone a personality change.</p>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "6cc44624",
      "audio": ""
    },
    {
      "text": "A 57-year-old man comes to the physician due to skin discoloration, anorexia, and unintentional weight loss of 6 kg over the past 3 months. He also reports dark urine and pale stools. The patient has no fever, abdominal pain, constipation, or diarrhea. He has a history of hypertension and hyperlipidemia. The patient does not use tobacco, alcohol, or illicit drugs. His vital signs are within normal limits. BMI is 32 kg/m2. Scleral icterus is present. An enlarged, non-tender gallbladder is palpated below the right costal margin. There are no ascites. Abdominal imaging in this patent would most likely reveal which of the following?",
      "options": [
        {
          "label": "A",
          "text": "Clot in the portal vein",
          "correct": false
        },
        {
          "label": "B",
          "text": "Gallstone obstructing the cystic duct",
          "correct": false
        },
        {
          "label": "C",
          "text": "Intra and extrahepatic biliary tract dilation",
          "correct": true
        },
        {
          "label": "D",
          "text": "Intrahepatic biliary cyst",
          "correct": false
        }
      ],
      "correct_answer": "C. Intra and extrahepatic biliary tract dilation",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Solution:</strong></p><p>Intra and extrahepatic biliary tract dilation This patient's most likely diagnosis is pancreatic cancer. The presentation can vary depending on the tumor's location. Most (60%-70%) cancers occur in the head of the pancreas. As these tumors expand, they compress the pancreatic duct and common bile duct (leading to painless jaundice), sometimes seen on imaging as the double duct sign. Subsequent backup of bile leads to intra-and extrahepatic biliary duct dilation and a non-tender, distended gallbladder at the right costal margin (Courvoisier sign). Jaundice can also lead to pruritus, pale stools, and dark urine. In contrast, cancers in the body or tail of the pancreas usually present with abdominal pain but Without jaundice.</p>\n<p><strong>Highyeild:</strong></p><p>Carcinoma Pancreas is a type of cancer that originates in the pancreas, with the most common type being pancreatic ductal adenocarcinoma (PDAC). The majority of PDAC cases occur in the head of the pancreas, with a smaller percentage occurring in the body and tail. Management: More than 85% of patients with ductal adenocarcinoma have advanced disease and are not suitable for resection. If imaging shows a potentially resectable tumor , surgical resection should be considered as it offers the only chance of a cure, albeit a small one. For patients with locally advanced or metastatic disease , the primary objective should be to relieve symptoms, improve quality of life, and extend survival, rather than achieving a cure. Patients with pancreatic cancer fall into four categories: resectable, borderline resectable, locally advanced and unresectable, and metastatic. Resectable patients should be offered surgery followed by adjuvant chemotherapy. Borderline resectable patients may be offered neoadjuvant chemotherapy with or without chemoradiotherapy, followed by surgical resection if the disease has been downstaged. Adjuvant therapy should follow. Locally advanced and unresectable patient s should be offered systemic chemotherapy , with surgery being a possibility in a small cohort who get downstaged. Metastatic patients should be offered systemic chemotherapy. If a cystic tumor is encountered, regardless of size, surgical resection should be considered as it carries a reasonable chance of cure. Tumors of the ampulla have a good prognosis and should be resected if possible, as should some rare tumors and neuroendocrine lesions.</p>\n<p><strong>Random:</strong></p><p>Explanation for incorrect options: - Option: A. Portal-vein thrombosis (PVT) is most often associated with cirrhosis. Acute PVT can present with gradual or sudden-onset abdominal pain, whereas chronic PVT most often presents as variceal bleeding. This patient's 2-month history of weight loss and jaundice is more consistent with pancreatic cancer. Option: B. Gallstones intermittently blocking the cystic duct could lead to intermittent biliary colic symptoms but are less likely to cause icterus, weight loss, and enlarged gallbladder. Option: D. Intrahepatic biliary cysts are an uncommon cause of abdominal pain and jaundice. These cysts tend to occur more frequently in women and children. In addition, intrahepatic biliary cysts usually do not cause an enlarged gallbladder.</p>\n<p><strong>Extraedge:</strong></p><p>During an examination, physicians should look for signs of jaundice, weight loss, a palpable liver, and a palpable gallbladder. Courvoisier first noticed the association between an enlarged gallbladder and pancreatic tumors in 1890. Patients with a recent diabetes diagnosis and upper abdominal symptoms, especially those above 50 years of age with no family history or obesity, should be suspected of having pancreatic tumors. Unexplained pancreatitis may also be a sign of tumors and should be followed up with imaging.</p>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "2e4bc449",
      "audio": ""
    },
    {
      "text": "A 53-year-old man comes to the physician complaining of fatigue. It is difficult for him to get up in the morning and go to work. He tires easily at work and goes to bed early due to feeling tired and sleepy. He also describes recent upper abdominal pain that is constant and interferes with his sleep. The patient's appetite is poor, and he has lost 7 kg during the last month. He has no other medical problems. His medications include over-the-counter ranitidine. He fell down and hit his head 2 months ago. He is a chronic smoker with a 30-pack-year history. Physical examination is significant for tenderness and fullness in the epigastrium. Which of the following is the most likely diagnosis?",
      "options": [
        {
          "label": "A",
          "text": "Chronic subdural hematoma",
          "correct": false
        },
        {
          "label": "B",
          "text": "Duodenal ulcer",
          "correct": false
        },
        {
          "label": "C",
          "text": "Major depressive episode",
          "correct": false
        },
        {
          "label": "D",
          "text": "Pancreatic cancer",
          "correct": true
        }
      ],
      "correct_answer": "D. Pancreatic cancer",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Solution:</strong></p><p>Pancreatic cancer This patient has epigastric pain/tenderness and weight loss in the setting of nonspecific systemic symptoms and significant smoking history. This combination strongly suggests a malignancy affecting the upper gastrointestinal tract or associated solid organs, such as the liver, gallbladder, or pancreas. Among the choices listed, pancreatic adenocarcinoma is the most likely diagnosis.</p>\n<p><strong>Highyeild:</strong></p><p>Carcinoma Pancreas is a type of cancer that originates in the pancreas, with the most common type being pancreatic ductal adenocarcinoma (PDAC). The majority of PDAC cases occur in the head of the pancreas, with a smaller percentage occurring in the body and tail. Management: More than 85% of patients with ductal adenocarcinoma have advanced disease and are not suitable for resection. If imaging shows a potentially resectable tumor , surgical resection should be considered as it offers the only chance of a cure, albeit a small one. For patients with locally advanced or metastatic disease , the primary objective should be to relieve symptoms, improve quality of life, and extend survival, rather than achieving a cure. Patients with pancreatic cancer fall into four categories: resectable, borderline resectable, locally advanced and unresectable, and metastatic. Resectable patients should be offered surgery followed by adjuvant chemotherapy. Borderline resectable patients may be offered neoadjuvant chemotherapy with or without chemoradiotherapy, followed by surgical resection if the disease has been downstaged. Adjuvant therapy should follow. Locally advanced and unresectable patient s should be offered systemic chemotherapy , with surgery being a possibility in a small cohort who get downstaged. Metastatic patients should be offered systemic chemotherapy. If a cystic tumor is encountered, regardless of size, surgical resection should be considered as it carries a reasonable chance of cure. Tumors of the ampulla have a good prognosis and should be resected if possible, as should some rare tumors and neuroendocrine lesions.</p>\n<p><strong>Random:</strong></p><p>Explanation for incorrect options: - Option: A. Chronic subdural hematoma from trauma would be more likely in an elderly person and typically presents with headache, personality changes, seizures, confusion, or hemiparesis. Abdominal pain and tenderness with anorexia and weight loss are not expected. Option: B. Duodenal ulcers can also cause burning epigastric pain. However, the pain is typically periodic and relieved by food, as it is generally a result of acid secretion in the absence of a food buffer. Anorexia and weight loss are less common. Antisecretory therapy with proton pump inhibitors or H2 receptor antagonists generally provides some relief. This patient describes constant pain accompanied by anorexia, weight loss, and systemic symptoms, which should raise suspicion of malignancy. Option: C. A major depressive episode could be responsible for fatigue, anorexia, and weight loss, but abdominal pain and tenderness would not be typical. Even if a primary mood disorder is suspected, localized pain with weight loss usually warrants evaluation for occult malignancy.</p>\n<p><strong>Extraedge:</strong></p><p>During an examination, physicians should look for signs of jaundice, weight loss, a palpable liver, and a palpable gallbladder. Courvoisier first noticed the association between an enlarged gallbladder and pancreatic tumors in 1890. Patients with a recent diabetes diagnosis and upper abdominal symptoms, especially those above 50 years of age with no family history or obesity, should be suspected of having pancreatic tumors. Unexplained pancreatitis may also be a sign of tumors and should be followed up with imaging.</p>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "93506efe",
      "audio": ""
    },
    {
      "text": "A 53-year-old woman comes to the physician due to worsening epigastric pain over the last 2 months. The pain, which is worse at night, was initially intermittent but is now somewhat constant and radiates to the back She has lost 6.8 kg over the past 3 months. The patient reports no change in the color of stools or urine. Two years ago, she was diagnosed with idiopathic chronic pancreatitis and started pancreatic enzyme replacement therapy. The patient initially had diarrhea, epigastric discomfort, and flatulence that improved with pancreatic enzymes. She does not use tobacco, alcohol, or illicit drugs. Vital signs are within normal limits. Her BMI is 21 kg/m2 There is no jaundice. Abdominal examination demonstrates mild epigastric tenderness on deep palpation. Laboratory results are as follows: Alkaline phosphatase 54U/L SGOT 28U/L SGPT 25U/L Amylase 45U/L Lipase 31U/L Which of the following is the most appropriate next step in the management of this patient?",
      "options": [
        {
          "label": "A",
          "text": "Cancer-associated antigen testing",
          "correct": false
        },
        {
          "label": "B",
          "text": "CT scan of the abdomen with contrast",
          "correct": true
        },
        {
          "label": "C",
          "text": "Endoscopic retrograde cholangiopancreatography",
          "correct": false
        },
        {
          "label": "D",
          "text": "Intensification of pancreatic enzyme replacement therapy",
          "correct": false
        }
      ],
      "correct_answer": "B. CT scan of the abdomen with contrast",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Solution:</strong></p><p>CT scan of the abdomen with contrast This patient's worsening epigastric pain and weight loss in the setting of idiopathic chronic pancreatitis suggest pancreatic cancer. The presentation and workup vary depending on the tumor location. Classic manifestations include weight loss and insidious onset of abdominal pain (usually epigastric, and radiating to the back), which is worse at night, with eating, or when lying supine. Cancers in the head of the pancreas is typically present with jaundice (common bile duct obstruction, elevated alkaline phosphatase and bilirubin) and steatorrhea (pancreatic exocrine insufficiency or pancreatic duct blockage). In patients with these findings, abdominal ultrasound is preferred for detecting pancreatic head tumors and excluding other potential causes of biliary obstruction (eg, choledocholithiasis). Cancers in the body and tail usually do not present with obstructive jaundice. An abdominal CT scan is preferred (more sensitive and specific) and helps exclude other conditions. Ultrasound is less sensitive for visualizing the pancreatic body and tail (due to overlying bowel gas) and for detecting smaller (<3 cm) tumors.</p>\n<p><strong>Highyeild:</strong></p><p>Carcinoma Pancreas is a type of cancer that originates in the pancreas, with the most common type being pancreatic ductal adenocarcinoma (PDAC). The majority of PDAC cases occur in the head of the pancreas, with a smaller percentage occurring in the body and tail. Management: More than 85% of patients with ductal adenocarcinoma have advanced disease and are not suitable for resection. If imaging shows a potentially resectable tumor , surgical resection should be considered as it offers the only chance of a cure, albeit a small one. For patients with locally advanced or metastatic disease , the primary objective should be to relieve symptoms, improve quality of life, and extend survival, rather than achieving a cure. Patients with pancreatic cancer fall into four categories: resectable, borderline resectable, locally advanced and unresectable, and metastatic. Resectable patients should be offered surgery followed by adjuvant chemotherapy. Borderline resectable patients may be offered neoadjuvant chemotherapy with or without chemoradiotherapy, followed by surgical resection if the disease has been downstaged. Adjuvant therapy should follow. Locally advanced and unresectable patient s should be offered systemic chemotherapy , with surgery being a possibility in a small cohort who get downstaged. Metastatic patients should be offered systemic chemotherapy. If a cystic tumor is encountered, regardless of size, surgical resection should be considered as it carries a reasonable chance of cure. Tumors of the ampulla have a good prognosis and should be resected if possible, as should some rare tumors and neuroendocrine lesions.</p>\n<p><strong>Random:</strong></p><p>Explanation for incorrect options: - Option: A. Cancer-associated antigen 19-9, a tumor marker associated with pancreatic cancer, is not recommended for screening due to variable sensitivity and low specificity. Option: C. Endoscopic retrograde cholangiopancreatography is more invasive than a CT scan, and is reserved for patients with cholestasis (from the tumor compressing the biliary system) who may require an intervention (eg, stenting}. Option: D. Pancreatic enzyme replacement therapy is typically titrated based on the patient's clinical symptoms and stool fat content. However, this patient does not need a dose adjustment as her symptoms (eg, bloating, diarrhea) improved with initial therapy.</p>\n<p><strong>Extraedge:</strong></p><p>During an examination, physicians should look for signs of jaundice, weight loss, a palpable liver, and a palpable gallbladder. Courvoisier first noticed the association between an enlarged gallbladder and pancreatic tumors in 1890. Patients with a recent diabetes diagnosis and upper abdominal symptoms, especially those above 50 years of age with no family history or obesity, should be suspected of having pancreatic tumors. Unexplained pancreatitis may also be a sign of tumors and should be followed up with imaging.</p>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "880c98b9",
      "audio": ""
    },
    {
      "text": "A 54-year-old man comes to the physician for a regular health check-up. He is a chronic smoker and has consumed 1 to 2 beers 2 to 3 times a week for the past 10 years. He also drinks 6 to 7 cups of coffee daily. The patient was diagnosed with type 2 diabetes mellitus 5 years ago and takes metformin. Blood pressure is 130/80 mm Hg and body mass index is 29 kg/m2. Random blood sugar is 190 mg/dl. His older brother died of pancreatic cancer at age 58, and the patient is worried that he might also develop pancreatic cancer. Which of the following interventions would have the greatest impact on decreasing this patient's risk of pancreatic cancer?",
      "options": [
        {
          "label": "A",
          "text": "Achieve better glycemic control with insulin",
          "correct": false
        },
        {
          "label": "B",
          "text": "Stop alcohol intake",
          "correct": false
        },
        {
          "label": "C",
          "text": "Stop metformin",
          "correct": false
        },
        {
          "label": "D",
          "text": "Stop smoking",
          "correct": true
        }
      ],
      "correct_answer": "D. Stop smoking",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Solution:</strong></p><p>Stop smoking Pancreatic cancer usually occurs after age 45 and is more common in men and African American patients. However, it is usually diagnosed relatively late in the disease course and has a high mortality rate. The major hereditary risk factors for pancreatic cancer include first-degree relatives with pancreatic cancer, hereditary pancreatitis, and germline mutations (eg, BRCA1, BRCA2, Peutz-Jeghers syndrome ). Environmental risk factors include cigarette smoking, nonhereditary chronic pancreatitis, and obesity with low physical activity. Cigarette smoking is the most consistent reversible risk factor for pancreatic cancer. The risk of cancer increases significantly with the number of cigarettes consumed, and heavy smokers have nearly 2-3 times higher risk than nonsmokers. Some studies estimate that smoking cessation could reduce pancreatic cancer deaths by 25%.</p>\n<p><strong>Highyeild:</strong></p><p>Carcinoma Pancreas is a type of cancer that originates in the pancreas, with the most common type being pancreatic ductal adenocarcinoma (PDAC). The majority of PDAC cases occur in the head of the pancreas, with a smaller percentage occurring in the body and tail. Management: More than 85% of patients with ductal adenocarcinoma have advanced disease and are not suitable for resection. If imaging shows a potentially resectable tumor , surgical resection should be considered as it offers the only chance of a cure, albeit a small one. For patients with locally advanced or metastatic disease , the primary objective should be to relieve symptoms, improve quality of life, and extend survival, rather than achieving a cure. Patients with pancreatic cancer fall into four categories: resectable, borderline resectable, locally advanced and unresectable, and metastatic. Resectable patients should be offered surgery followed by adjuvant chemotherapy. Borderline resectable patients may be offered neoadjuvant chemotherapy with or without chemoradiotherapy, followed by surgical resection if the disease has been downstaged. Adjuvant therapy should follow. Locally advanced and unresectable patient s should be offered systemic chemotherapy , with surgery being a possibility in a small cohort who get downstaged. Metastatic patients should be offered systemic chemotherapy. If a cystic tumor is encountered, regardless of size, surgical resection should be considered as it carries a reasonable chance of cure. Tumors of the ampulla have a good prognosis and should be resected if possible, as should some rare tumors and neuroendocrine lesions.</p>\n<p><strong>Random:</strong></p><p>Explanation for incorrect options: - Option: A. Long-standing diabetes is a risk factor for pancreatic cancer, and conversely, new-onset diabetes is often a sign of occult pancreatic cancer. The effect of diabetic treatment on pancreatic cancer risk s variable; insulin and insulin secretagogues (eg, sulfonylureas) are associated with an increased risk, whereas metformin is associated with a lower risk. Option: B. Heavy alcohol use can lead to chronic pancreatitis, which is associated with a slightly higher risk of pancreatic cancer. Option: C. Neither discontinuing metformin nor initiating insulin would be likely to lower this patient's cancer risk, regardless of improved glycemic control.</p>\n<p><strong>Extraedge:</strong></p><p>During an examination, physicians should look for signs of jaundice, weight loss, a palpable liver, and a palpable gallbladder. Courvoisier first noticed the association between an enlarged gallbladder and pancreatic tumors in 1890. Patients with a recent diabetes diagnosis and upper abdominal symptoms, especially those above 50 years of age with no family history or obesity, should be suspected of having pancreatic tumors. Unexplained pancreatitis may also be a sign of tumors and should be followed up with imaging.</p>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "40225758",
      "audio": ""
    },
    {
      "text": "A 52-year-old man comes to the physician because of a 4-month history of yellow discoloration of the skin. He reports a loss of appetite. He lives with his wife and three children in a rural town where he works as a safety inspector at the local nuclear power plant. He is not physically active and his diet consists mostly of donuts and highly caloric processed food. He does not smoke but drinks 5 cans of beer daily. He is 182 cm tall and weighs 101 kg; his BMI is 30 kg/m2. His vital signs are within normal limits. Physical examination shows jaundice of the skin and scleral icterus. There is a palpable, non-tender mass below the right costal margin. Scratch marks are seen on the extremities. Which of the following is the most likely cause of this patient's symptoms?",
      "options": [
        {
          "label": "A",
          "text": "Infection",
          "correct": false
        },
        {
          "label": "B",
          "text": "Lithiasis",
          "correct": false
        },
        {
          "label": "C",
          "text": "Hemolysis",
          "correct": false
        },
        {
          "label": "D",
          "text": "Neoplasia",
          "correct": true
        }
      ],
      "correct_answer": "D. Neoplasia",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Solution:</strong></p><p>Neoplasia This patient most likely has neoplasia of the gastrointestinal tract that has resulted in biliary system obstruction , as evidenced by his pruritus, loss of appetite, and Courvoisier sign (enlarged gallbladder and painless jaundice). Possible etiologies include pancreatic head carcinoma, cholangiocarcinoma, and hepatocellular carcinoma (HCC). Exposure to ionizing radiation (e.g., from working at a power plant) increases the risk of malignancy. Heavy alcohol consumption is a risk factor for HCC and pancreatic cancer, whereas obesity is a risk factor for pancreatic adenocarcinoma . Diagnostic evaluation should include liver function tests, parameters of cholestasis, and tumor markers (e.g., alpha-fetoprotein, CA 19-9, CEA).</p>\n<p><strong>Highyeild:</strong></p><p>Carcinoma Pancreas is a type of cancer that originates in the pancreas, with the most common type being pancreatic ductal adenocarcinoma (PDAC). The majority of PDAC cases occur in the head of the pancreas, with a smaller percentage occurring in the body and tail. Management: More than 85% of patients with ductal adenocarcinoma have advanced disease and are not suitable for resection. If imaging shows a potentially resectable tumor , surgical resection should be considered as it offers the only chance of a cure, albeit a small one. For patients with locally advanced or metastatic disease , the primary objective should be to relieve symptoms, improve quality of life, and extend survival, rather than achieving a cure. Patients with pancreatic cancer fall into four categories: resectable, borderline resectable, locally advanced and unresectable, and metastatic. Resectable patients should be offered surgery followed by adjuvant chemotherapy. Borderline resectable patients may be offered neoadjuvant chemotherapy with or without chemoradiotherapy, followed by surgical resection if the disease has been downstaged. Adjuvant therapy should follow. Locally advanced and unresectable patient s should be offered systemic chemotherapy , with surgery being a possibility in a small cohort who get downstaged. Metastatic patients should be offered systemic chemotherapy. If a cystic tumor is encountered, regardless of size, surgical resection should be considered as it carries a reasonable chance of cure. Tumors of the ampulla have a good prognosis and should be resected if possible, as should some rare tumors and neuroendocrine lesions.</p>\n<p><strong>Random:</strong></p><p>Explanation for incorrect options: - Option: A. This patient's loss of appetite and jaundice may result from hepatobiliary infection (e.g., viral hepatitis, acute cholangitis, acute cholecystitis). Hepatitis can also cause pruritus, a feature also seen in this patient. However, none of these infections would explain the positive Courvoisier sign (palpable, non-tender gall bladder, and painless jaundice). Rather, acute cholecystitis causes a positive Murphy sign, acute cholangitis causes RUQ tenderness, and hepatitis typically causes tender hepatomegaly. Furthermore, this patient lacks other features of infection, including fever, nausea, vomiting, and abdominal pain. Option: B. Cholecystolithiasis is the presence of gallstones in the gallbladder. Although this condition is typically asymptomatic, some individuals may present with symptoms of biliary colic, which are absent here. Choledocholithiasis is characterized by stones in the common bile duct and can manifest with jaundice and pruritus, both of which are seen here. However, choledocholithiasis would not explain this patient's positive Courvoisier sign. In addition, other typical features of choledocholithiasis (e.g., RUQ pain, nausea, vomiting, pale stool, dark urine) are absent in this patient. Option: C. Hemolysis , the breakdown of RBCs, is the cause of hemolytic anemia, which can manifest with jaundice. However, hemolytic anemia would not explain this patient's loss of appetite and positive Courvoisier sign (palpable, non-tender gall bladder, and painless jaundice). Moreover, this patient lacks other features of anemia, including fatigue, weakness, and pallor.</p>\n<p><strong>Extraedge:</strong></p><p>During an examination, physicians should look for signs of jaundice, weight loss, a palpable liver, and a palpable gallbladder. Courvoisier first noticed the association between an enlarged gallbladder and pancreatic tumors in 1890. Patients with a recent diabetes diagnosis and upper abdominal symptoms, especially those above 50 years of age with no family history or obesity, should be suspected of having pancreatic tumors. Unexplained pancreatitis may also be a sign of tumors and should be followed up with imaging.</p>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "08031967",
      "audio": ""
    },
    {
      "text": "A 68-year-old man comes to the physician for the evaluation of abdominal pain over the past month. The patient describes epigastric pain that radiates to the back. He also reports a 10-kg weight loss over the past 6 months. He has a history of untreated type 2 diabetes mellitus. He has not seen a doctor in 15 years. He is retired and spends most of his time at home watching TV. He rarely cooks and mainly eats fast food. He has smoked one pack of cigarettes daily for the past 50 years. He drinks 2-3 cans of beer per day. He appears pale. His temperature is 37\u00b0C (98.6\u00b0F), his pulse is 80/min, and his blood pressure is 150/90 mm Hg. Physical examination shows jaundice of the conjunctivae and the skin. The abdomen is soft, with no rebound or guarding. Laboratory studies show a serum glucose concentration of 260 mg/dL. Abdominal sonography shows an enlargement of the gallbladder. Which of the following is most likely to have contributed to this patient's condition?",
      "options": [
        {
          "label": "A",
          "text": "Smoking history",
          "correct": true
        },
        {
          "label": "B",
          "text": "Lack of physical activity",
          "correct": false
        },
        {
          "label": "C",
          "text": "Long-term use of aspirin",
          "correct": false
        },
        {
          "label": "D",
          "text": "Poor dietary habits",
          "correct": false
        }
      ],
      "correct_answer": "A. Smoking history",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Solution:</strong></p><p>Smoking history The patient's findings are suggestive of pancreatic cancer. Cigarette smoking significantly increases the risk of pancreatic cancer. It accounts for about 25% of all cases and it is considered the most significant environmental contributing factor. This patient's history of 50-pack years of smoking is likely to have been the main risk factor for developing pancreatic cancer.</p>\n<p><strong>Highyeild:</strong></p><p>Carcinoma Pancreas is a type of cancer that originates in the pancreas, with the most common type being pancreatic ductal adenocarcinoma (PDAC). The majority of PDAC cases occur in the head of the pancreas, with a smaller percentage occurring in the body and tail. Management: More than 85% of patients with ductal adenocarcinoma have advanced disease and are not suitable for resection. If imaging shows a potentially resectable tumor , surgical resection should be considered as it offers the only chance of a cure, albeit a small one. For patients with locally advanced or metastatic disease , the primary objective should be to relieve symptoms, improve quality of life, and extend survival, rather than achieving a cure. Patients with pancreatic cancer fall into four categories: resectable, borderline resectable, locally advanced and unresectable, and metastatic. Resectable patients should be offered surgery followed by adjuvant chemotherapy. Borderline resectable patients may be offered neoadjuvant chemotherapy with or without chemoradiotherapy, followed by surgical resection if the disease has been downstaged. Adjuvant therapy should follow. Locally advanced and unresectable patient s should be offered systemic chemotherapy , with surgery being a possibility in a small cohort who get downstaged. Metastatic patients should be offered systemic chemotherapy. If a cystic tumor is encountered, regardless of size, surgical resection should be considered as it carries a reasonable chance of cure. Tumors of the ampulla have a good prognosis and should be resected if possible, as should some rare tumors and neuroendocrine lesions.</p>\n<p><strong>Random:</strong></p><p>Explanation for incorrect options: - Option: B. Physical activity is an important factor in maintaining good health as it helps reduce weight, lower insulin levels, and boost the immune system. It is a known protective factor for colon, breast, and endometrial cancer, and may also reduce the risk of gastric, esophageal, liver, and kidney tumors. Although the lack of physical activity has been linked to increased risk for the development of pancreatic cancer, there is another risk factor that is even more strongly associated. Option: C. Long-term use of aspirin has not been linked with either an increased or decreased risk for pancreatic cancer. However, long-term use of low-dose aspirin has been shown to have a protective effect on colorectal cancer. Although the exact mechanism is not yet well understood, it is believed that the inhibition of prostaglandins decreases angiogenesis. Option: D. The relationship between poor dietary habits consisting of fat-rich food and pancreatic cancer is not well established. Studies have been unable to show consistent results that link specific diets to pancreatic cancer. However, a diet rich in fiber and vegetables is considered a protective factor for colorectal cancer and diverticular disease.</p>\n<p><strong>Extraedge:</strong></p><p>During an examination, physicians should look for signs of jaundice, weight loss, a palpable liver, and a palpable gallbladder. Courvoisier first noticed the association between an enlarged gallbladder and pancreatic tumors in 1890. Patients with a recent diabetes diagnosis and upper abdominal symptoms, especially those above 50 years of age with no family history or obesity, should be suspected of having pancreatic tumors. Unexplained pancreatitis may also be a sign of tumors and should be followed up with imaging.</p>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "af813dad",
      "audio": ""
    },
    {
      "text": "A 41-year-old man comes to the physician because of severe epigastric pain for a week. The pain is constant and he describes it as 6 out of 10 in intensity. The pain radiates to his back and is worse after meals. He has had several episodes of nausea and vomiting during this period. He has taken ibuprofen for multiple similar episodes of pain during the past 6 months. He has a 12-year history of drinking 3 to 4 pints of rum daily. He has been hospitalized three times for severe abdominal pain in the past 3 years. He appears ill. His temperature is 37\u00b0C (98.6\u00b0F), his pulse is 87/min, and his blood pressure is 110/70 mm Hg. There is severe epigastric tenderness to palpation. Bowel sounds are normal. Cardiopulmonary examination shows no abnormalities. Laboratory studies show: Serum Glucose 96 mg/dL Creatinine 1.1 mg/dL Amylase 150 U/L. A CT of the abdomen is shown. Which of the following is the most appropriate long-term management for this patient?",
      "options": [
        {
          "label": "A",
          "text": "Gluten-free diet",
          "correct": false
        },
        {
          "label": "B",
          "text": "Whipple procedure",
          "correct": false
        },
        {
          "label": "C",
          "text": "Opioid therapy",
          "correct": false
        },
        {
          "label": "D",
          "text": "Pancreatic enzyme therapy",
          "correct": true
        }
      ],
      "correct_answer": "D. Pancreatic enzyme therapy",
      "question_images": [
        "https://dbmi-data.s3.ap-south-1.amazonaws.com/photos-1683768307027-QTDS051013IMG1.JPG"
      ],
      "explanation_images": [],
      "explanation": "<p><strong>Solution:</strong></p><p>Pancreatic enzyme therapy The patient has chronic pancreatitis. Pancreatic enzyme therapy with orally administered enzyme preparations is recommended for the treatment of chronic pancreatitis. Pancreatic enzymes improve the breakdown and absorption of food, resulting in weight gain and reduced stool frequency. This therapy also reduces the secretion of duodenal cholecystokinin, leading to decreased pancreatic stimulation and less pain. In addition, this patient should be counseled on lifestyle modifications regarding cessation of alcohol and smoking, consumption of small meals low in fat, and adequate hydration.</p>\n<p><strong>Highyeild:</strong></p><p>Chronic pancreatitis can be caused by several factors, including hereditary pancreatitis, cystic fibrosis (CF), infantile malnutrition, and an unexplained idiopathic group. Treat addiction by helping the patient to stop alcohol and tobacco consumption and involving a dependency counselor or a psychologist Alleviate abdominal pain by eliminating obstructive factors and escalating analgesia, referring to a pain management specialist, and considering CT/EUS-guided coeliac axis block for intractable pain Nutritional and pharmacological measures including a low-fat, high-protein, and carbohydrate-rich diet, pancreatic enzyme supplementation , correcting malabsorption, micronutrient therapy, steroids, medium-chain triglycerides, and reducing gastric secretions Treat diabetes mellitus with insulin or oral hypoglycemic agents.</p>\n<p><strong>Random:</strong></p><p>Explanation for incorrect options: - Option: A. A gluten-free diet is the recommended treatment for celiac disease. A patient with celiac disease would present with some of the features seen in this patient, such as abdominal pain and weight loss. However, celiac disease does not cause pancreatic calcifications on abdominal CT. Given the CT findings and the presence of epigastric tenderness, a diagnosis of pancreatitis is more likely. Option: B. Whipple's procedure provides effective pain relief in 85% of patients with chronic pancreatitis. However, a surgical approach to pain relief is only considered if conservative management (i.e., medical therapy, and lifestyle modifications) is not effective. In addition, the Whipple procedure is the first-line treatment option in patients with suspected pancreatic cancer. Since this patient has not attempted conservative therapy and the CT scan shows no evidence of pancreatic cancer, a surgical approach would not be appropriate. Option: C. Oral analgesics should be prescribed for pain relief in patients with chronic pancreatitis. However, opioids should not be used as a first-line drug for pain control because of the risk of opioid addiction and should only be considered in the case of severe pain. Substance use disorder related to prescription opioids is a serious public health issue affecting nearly 1% of the US population, and every attempt must be made to adhere to the WHO analgesic pain ladder.</p>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "84b40a70",
      "audio": ""
    },
    {
      "text": "A 49-year-old man comes to the physician for a routine health maintenance examination. He feels well and has no history of serious illness. He has smoked one pack of cigarettes daily for the past 25 years and drinks two to three glasses of wine weekly. This patient should be counseled about increased risk for which of the following conditions?",
      "options": [
        {
          "label": "A",
          "text": "Pancreatic Adenocarcinoma",
          "correct": true
        },
        {
          "label": "B",
          "text": "Gastric MALT lymphoma",
          "correct": false
        },
        {
          "label": "C",
          "text": "Esophageal varices",
          "correct": false
        },
        {
          "label": "D",
          "text": "Porcelain gall bladder",
          "correct": false
        }
      ],
      "correct_answer": "A. Pancreatic Adenocarcinoma",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Solution:</strong></p><p>Pancreatic Adenocarcinoma An upper gastrointestinal endoscopy is useful to diagnose a pathology in the upper gastrointestinal tract (e.g., peptic ulcer disease, GERD, malignancy) that may present with recurrent upper abdominal pain and weight loss, as seen in this patient. However, these symptoms in conjunction with steatorrhea and chronic alcohol abuse, make chronic pancreatitis (CP) more likely. Steatorrhea occurs in chronic pancreatitis due to a deficiency of pancreatic lipase. Upper GI endoscopy cannot visualize the pancreas and is not a recommended diagnostic tool for CP.</p>\n<p><strong>Highyeild:</strong></p><p>Chronic pancreatitis can be caused by several factors, including hereditary pancreatitis, cystic fibrosis (CF), infantile malnutrition, and an unexplained idiopathic group. Treat addiction by helping the patient to stop alcohol and tobacco consumption and involving a dependency counselor or a psychologist Alleviate abdominal pain by eliminating obstructive factors and escalating analgesia, referring to a pain management specialist, and considering CT/EUS-guided coeliac axis block for intractable pain Nutritional and pharmacological measures including a low-fat, high-protein, and carbohydrate-rich diet, pancreatic enzyme supplementation , correcting malabsorption, micronutrient therapy, steroids, medium-chain triglycerides, and reducing gastric secretions Treat diabetes mellitus with insulin or oral hypoglycemic agents.</p>\n<p><strong>Random:</strong></p><p>Explanation for incorrect options: - Option: B. Gastric MALT lymphoma is associated with Helicobacter pylori infection in up to 90% of cases. Since this patient lacks any of the clinical features of H. pylori infection (e.g., epigastric pain, nausea, vomiting), he is not expected to be at increased risk for this malignancy. Option: C. Esophageal varices can develop due to portal hypertension, which is typically seen in patients with liver cirrhosis and a history of extensive alcohol use. Extensive alcohol consumption is defined as consuming more than 210 g of pure alcohol (\u223c 15 glasses of wine) per week in men and more than 140 g (\u223c 10 glasses of wine) per week in women. However, this patient consumes three glasses of wine per week, which is not considered a significant risk factor for developing esophageal varices due to alcoholic liver disease. Option: D. Porcelain gallbladder is a complication of chronic gallbladder inflammation (e.g., chronic cholecystitis). This patient, however, lacks a history of cholecystitis and thus is not expected to be at increased risk for porcelain gallbladder.</p>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "46bad355",
      "audio": ""
    },
    {
      "text": "A previously healthy 46-year-old man comes to the physician because of a 3-week history of progressively worsening jaundice, generalized itching, and epigastric discomfort. He also complains of nausea and loss of appetite. His stools have looked like clay for the past week. He is sexually active with multiple partners and does not use protection. His vital signs are within normal limits. Examination shows jaundice and scleral icterus. Superficial excoriations are seen on all limbs. Abdominal examination shows no abnormalities. Serum studies show a fasting glucose level of 198 mg/dL, total bilirubin concentration of 10.6 mg/dL, direct bilirubin concentration of 9.8 mg/dl, and alkaline phosphatase activity of 450 U/L. Abdominal ultrasonography shows dilation of the biliary and pancreatic ducts and a 3-cm hypoechoic solid mass with irregular margins in the head of the pancreas. Elevation of which of the following serum findings is most specific for this patient's condition?",
      "options": [
        {
          "label": "A",
          "text": "Cancer antigen 125",
          "correct": false
        },
        {
          "label": "B",
          "text": "Anti HBc immunoglobulin M",
          "correct": false
        },
        {
          "label": "C",
          "text": "Elevated antineutrophilic cytoplasmic antibodies",
          "correct": false
        },
        {
          "label": "D",
          "text": "Cancer antigen 19- 9",
          "correct": true
        }
      ],
      "correct_answer": "D. Cancer antigen 19- 9",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Solution:</strong></p><p>Cancer antigen 19- 9 This patient most likely suffers from malignant biliary obstruction. CA 19-9 is a tumor marker that is elevated in non-malignant hepatobiliary disorders as well as various cancers, most importantly pancreatic adenocarcinoma. Other less sensitive and specific laboratory findings that are elevated in pancreatic cancer include carcinoembryonic antigen (CEA), and, in some cases, lipase levels. Tumor markers should be obtained for the purpose of disease monitoring rather than for confirmation of the diagnosis. Higher levels of CA 19-9 at initial presentation are associated with a worse prognosis.</p>\n<p><strong>Highyeild:</strong></p><p>Carcinoma Pancreas is a type of cancer that originates in the pancreas, with the most common type being pancreatic ductal adenocarcinoma (PDAC). The majority of PDAC cases occur in the head of the pancreas, with a smaller percentage occurring in the body and tail. Management: More than 85% of patients with ductal adenocarcinoma have advanced disease and are not suitable for resection. If imaging shows a potentially resectable tumor , surgical resection should be considered as it offers the only chance of a cure, albeit a small one. For patients with locally advanced or metastatic disease , the primary objective should be to relieve symptoms, improve quality of life, and extend survival, rather than achieving a cure. Patients with pancreatic cancer fall into four categories: resectable, borderline resectable, locally advanced and unresectable, and metastatic. Resectable patients should be offered surgery followed by adjuvant chemotherapy. Borderline resectable patients may be offered neoadjuvant chemotherapy with or without chemoradiotherapy, followed by surgical resection if the disease has been downstaged. Adjuvant therapy should follow. Locally advanced and unresectable patient s should be offered systemic chemotherapy , with surgery being a possibility in a small cohort who get downstaged. Metastatic patients should be offered systemic chemotherapy. If a cystic tumor is encountered, regardless of size, surgical resection should be considered as it carries a reasonable chance of cure. Tumors of the ampulla have a good prognosis and should be resected if possible, as should some rare tumors and neuroendocrine lesions.</p>\n<p><strong>Random:</strong></p><p>Explanation for incorrect options: - Option: A. Although an elevated CA 125 is positive in about half the cases of pancreatic cancer, it is both less sensitive and less specific than another tumor marker that also has prognostic value in the treatment of pancreatic cancer. Instead, an elevated CA 125 is especially sensitive and specific for ovarian cancers. Option: B. Anti-HBc immunoglobulin M is a serum marker for acute hepatitis B. While this patient has jaundice and presents with risk factors for hepatitis B infection (travel history, multiple sexual partners, unprotected sex), he does not have other signs of acute viral hepatitis such as fever or tender hepatomegaly. Moreover, in viral hepatitis, jaundice is not cholestatic but results from an acute hepatic dysfunction. Patients would thus present with mixed hyperbilirubinemia rather than just elevated direct bilirubin. Option: C. Perinuclear antineutrophil cytoplasmic antibodies (p-ANCA) are often found in patients with primary sclerosing cholangitis (PSC). Though PSC can also manifest with cholestasis, this condition does not cause the double-duct sign seen on imaging. Instead, beading of the extrahepatic and intrahepatic bile ducts would be seen. Jaundice in this patient is best explained by the pancreatic head mass detected on ultrasound.</p>\n<p><strong>Extraedge:</strong></p><p>During an examination, physicians should look for signs of jaundice, weight loss, a palpable liver, and a palpable gallbladder. Courvoisier first noticed the association between an enlarged gallbladder and pancreatic tumors in 1890. Patients with a recent diabetes diagnosis and upper abdominal symptoms, especially those above 50 years of age with no family history or obesity, should be suspected of having pancreatic tumors. Unexplained pancreatitis may also be a sign of tumors and should be followed up with imaging.</p>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "ebf709fa",
      "audio": ""
    },
    {
      "text": "A 52-year-old man reports weakness, sweating, tachycardia, confusion, and headache whenever he fasts for more than a few hours. He has prompt relief of symptoms when he eats. The physical exam reveals a BMI of 41 kg/m2 and a benign abdominal exam. Laboratory examination reveals an inappropriately high level of serum insulin during the episodes of fasting. Which of the following is the most appropriate treatment for this condition?",
      "options": [
        {
          "label": "A",
          "text": "Diet modification to include frequent meals",
          "correct": false
        },
        {
          "label": "B",
          "text": "Long-acting somatostatin analog octreotide",
          "correct": false
        },
        {
          "label": "C",
          "text": "Simple excision of the tumor",
          "correct": true
        },
        {
          "label": "D",
          "text": "Total pancreatectomy",
          "correct": false
        }
      ],
      "correct_answer": "C. Simple excision of the tumor",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Solution:</strong></p><p>Simple excision of the tumor The patient\u2019s presentation is classic for an These tumors are treated surgically, and simple excision of an adenoma is curative in the majority of cases. Seventy-five percent of these tumors are benign adenomas, and in 15% of affected patients, the adenomas are multiple. Tumors arise from the pancreatic \u03b2 cells and result in elevated levels of insulin. Symptoms relate to a rapidly falling blood glucose level and are caused by epinephrine release triggered by hypoglycemia (sweating, weakness, tachycardia). Cerebral symptoms of headache, confusion, visual disturbances, convulsions, and coma are caused by glucose deprivation of the brain. Whipple triad summarizes the clinical findings in patients with insulinomas: (1) attacks precipitated by fasting or exertion, (2) fasting blood glucose concentrations below 50 mg/dL, and (3) symptoms relieved by oral or intravenous glucose administration.</p>\n<p><strong>Highyeild:</strong></p><p>Insulinoma is the most common functioning tumor of the endocrine pancreas The average age at diagnosis is 45 years 97% of insulinomas are located in the pancreas (equally distributed in the head, body, and tail), while 3% are found in other areas such as the duodenum, splenic hilum, or gastrocolic ligament Insulinomas are typically small , with an average size of 0 to 1.5 cm The diagnostic hallmark of insulinoma is Whipple\u2019s triad , which includes symptoms of hypoglycemia, low blood glucose levels (40-50 mg/dL), and relief of symptoms after the administration of glucose Clinical features of insulinoma include sympathetic overactivity in response to hypoglycemia, CNS disturbance, significant weight gain, and a painless condition The gold standard test for the diagnosis of insulinoma is the 72-hour fasting test An insulin-to-glucose ratio > 0.4 is consistent with insulinoma</p>\n<p><strong>Random:</strong></p><p>Explanation for incorrect options: - Option: A. Dietary modification is not enough for the management of insulinoma it requires simple excision of the tumor Option: B & C. Octeriotide or pancreatectomy is not the management of choice in this patient, he requires just simple excision of the tumor</p>\n<p><strong>Extraedge:</strong></p><p>Localization techniques for insulinoma include angiography, portal venous sampling for insulin, and EUS with intra-operative palpation Treatment options for insulinoma include diazoxide, laparoscopic resection or enucleation, and distal pancreatectomy (depending on the location of the tumor) Streptozotocin, with or without 5-fluorouracil , is associated with improved survival in metastatic pancreatic endocrine tumors.</p>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "101ad89b",
      "audio": ""
    },
    {
      "text": "A 58-year-old man complains that his eyes are yellow. His bilirubin is 8mg/dl. His physical examination is unremarkable. A CT of the abdomen and pelvis shows a 3 cm mass in the head of the pancreas encasing the superior mesenteric artery. Cytology from the ERCP is positive for cancer. Which of the following is the most appropriate treatment for this patient?",
      "options": [
        {
          "label": "A",
          "text": "Pancreaticoduodenectomy",
          "correct": false
        },
        {
          "label": "B",
          "text": "Pancreaticoduodenectomy with the reconstruction of the superior mesenteric artery",
          "correct": false
        },
        {
          "label": "C",
          "text": "Total pancreatectomy",
          "correct": false
        },
        {
          "label": "D",
          "text": "Placement of metallic biliary stent and chemotherapy",
          "correct": true
        }
      ],
      "correct_answer": "D. Placement of metallic biliary stent and chemotherapy",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Solution:</strong></p><p>Placement of metallic biliary stent and chemotherapy The patient has unresectable (locally advanced) pancreatic cancer and needs chemotherapy and possibly radiation.</p>\n<p><strong>Highyeild:</strong></p><p>Chemotherapy and radiation are common treatments for locally advanced unresectable and metastatic pancreatic cancer. Systemic chemotherapy is typically used for stage IV metastatic disease , while chemotherapy and radiation may be used for locally advanced unresectable diseases. The role of radiation therapy in treating unresectable, locoregionally advanced pancreatic cancer is still controversial. Radiation therapy may slow the progression of local disease and alleviate or prevent symptoms such as pain, biliary obstruction, bleeding, and bowel obstruction. However, radiation therapy is not expected to be curative and can result in toxicity.</p>\n<p><strong>Random:</strong></p><p>Explanation for incorrect options: - Option:  A, B, and C. Unresectable tumors are those that have solid tumor contact with the SMA or celiac artery of >180\u00b0 or SMV/portal vein involvement or occlusion such that reconstruction would not be possible. Option D: Metallic stents are preferred for patients who are not candidates for surgery and will require long-term biliary drainage.</p>\n<p><strong>Extraedge:</strong></p><p>Stereotactic body radiotherapy (SBRT) is used to limit toxicity by targeting high-dose short-course radiation to enhance the local response prior to surgery. Gemcitabine is a chemotherapy drug approved by the FDA for use in pancreatic cancer in 1996. The results of chemotherapy regimens for pancreatic cancer are not impressive. Gemcitabine results in symptomatic improvement, improved pain control and performance status, and weight gain in patients with unresectable pancreatic cancer. However, survival is improved by only 1 to 2 months. Prior to gemcitabine, 5-fluorouracil (5-FU) was used as the standard treatment for unresectable pancreatic cancer. Both 5-FU and capecitabine are still used today, often as radiosensitizers during radiation therapy. Single-agent gemcitabine is commonly used in patients with a poor performance status</p>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "16802a56",
      "audio": ""
    },
    {
      "text": "A 63-year-old man complains of intense itching and jaundice of 6 weeks' duration. He has upper abdominal discomfort and has noticed of late that his urine is deep yellow and his stools are pale. He has some weight loss. On examination he is deeply jaundiced with scratch marks all over his body; abdominal examination reveals a globular discrete mass in the right upper quadrant. Which of the following is the most likely diagnosis?",
      "options": [
        {
          "label": "A",
          "text": "Acute pancreatitis",
          "correct": false
        },
        {
          "label": "B",
          "text": "Carcinoma of the head of the pancreas",
          "correct": true
        },
        {
          "label": "C",
          "text": "Chronic pancreatitis",
          "correct": false
        },
        {
          "label": "D",
          "text": "Pseudocyst of the pancreas",
          "correct": false
        }
      ],
      "correct_answer": "B. Carcinoma of the head of the pancreas",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Solution:</strong></p><p>Carcinoma of the head of the pancreas This patient has painless obstructive jaundice with a distended gall bladder and weight loss \u2013 classical features of carcinoma of the head of the pancreas. Clinically Courvoisier\u2019s sign will be positive. Besides all the usual blood tests, he needs an Ultrasound followed by a CT scan to see the solid mass in the head of the pancreas obstructing the lower end of the CBD. If there is evidence of secondaries in the abdomen, as there usually are, this is unresectable. After discussion in a multidisciplinary team meeting, plans for the best palliation should be made.</p>\n<p><strong>Highyeild:</strong></p><p>Carcinoma Pancreas is a type of cancer that originates in the pancreas, with the most common type being pancreatic ductal adenocarcinoma (PDAC). The majority of PDAC cases occur in the head of the pancreas, with a smaller percentage occurring in the body and tail. Management: More than 85% of patients with ductal adenocarcinoma have advanced disease and are not suitable for resection. If imaging shows a potentially resectable tumor , surgical resection should be considered as it offers the only chance of a cure, albeit a small one. For patients with locally advanced or metastatic disease , the primary objective should be to relieve symptoms, improve quality of life, and extend survival, rather than achieving a cure. Patients with pancreatic cancer fall into four categories: resectable, borderline resectable, locally advanced and unresectable, and metastatic. Resectable patients should be offered surgery followed by adjuvant chemotherapy. Borderline resectable patients may be offered neoadjuvant chemotherapy with or without chemoradiotherapy, followed by surgical resection if the disease has been downstaged. Adjuvant therapy should follow. Locally advanced and unresectable patient s should be offered systemic chemotherapy , with surgery being a possibility in a small cohort who get downstaged. Metastatic patients should be offered systemic chemotherapy. If a cystic tumor is encountered, regardless of size, surgical resection should be considered as it carries a reasonable chance of cure. Tumors of the ampulla have a good prognosis and should be resected if possible, as should some rare tumors and neuroendocrine lesions.</p>\n<p><strong>Random:</strong></p><p>Explanation for incorrect options: - Option: A. Acute pancreatitis - The common presentations include central abdominal pain that starts at a low intensity and gradually increases in severity. The pain may radiate to the back, may be associated with nausea and vomiting, and may be improved by sitting forward. Option: C. Chronic pancreatitis - patient presents with pain in the abdomen,weight loss, and steatorrhoea. Option: D. Pancreatic pseudocyst is defined as a localized collection of pancreatic secretions, usually rich in digestive enzymes, that is enclosed by a non-epithelialized wall and persists for more than 4 weeks. Treatment is either conservative or drainage of the pseudocyst.</p>\n<p><strong>Extraedge:</strong></p><p>During an examination, physicians should look for signs of jaundice, weight loss, a palpable liver, and a palpable gallbladder. Courvoisier first noticed the association between an enlarged gallbladder and pancreatic tumors in 1890. Patients with a recent diabetes diagnosis and upper abdominal symptoms, especially those above 50 years of age with no family history or obesity, should be suspected of having pancreatic tumors. Unexplained pancreatitis may also be a sign of tumors and should be followed up with imaging.</p>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "d75edbb6",
      "audio": ""
    },
    {
      "text": "A 54-year-old man complains of intermittent jaundice associated with itching. This is associated with anorexia, weight loss, and upper abdominal discomfort. On examination, the patient is anemic, has scratch marks over his body, is slightly jaundiced, and has a gall bladder that is just palpable. Which of the following is the most likely diagnosis?",
      "options": [
        {
          "label": "A",
          "text": "Acute pancreatitis",
          "correct": false
        },
        {
          "label": "B",
          "text": "Chronic pancreatitis",
          "correct": false
        },
        {
          "label": "C",
          "text": "Periampullary carcinoma",
          "correct": true
        },
        {
          "label": "D",
          "text": "Pseudocyst of the pancreas",
          "correct": false
        }
      ],
      "correct_answer": "C. Periampullary carcinoma",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Solution:</strong></p><p>Periampullary carcinoma This patient has intermittent obstructive jaundice (where the icterus waxes and wanes ) with a gall bladder that is minimally palpable. His anemia and weight loss should point to an underlying malignant lesion in the region of the lower end of the CBD. As the jaundice is intermittent, the diagnosis is obviously a periampullary carcinoma. In this condition, as the tumor grows, the patient\u2019s jaundice gets deeper; as the carcinoma outgrows its blood supply, there is necrosis and sloughing of cancer, resulting in the alleviation of jaundice.</p>\n<p><strong>Random:</strong></p><p>Explanation for incorrect options: - Option: A. Acute pancreatitis - The common presentations include central abdominal pain that starts at a low intensity and gradually increases in severity. The pain may radiate to the back, may be associated with nausea and vomiting, and may be improved by sitting forward. Option: B. Chronic pancreatitis - patient presents with pain in the abdomen,weight loss, and steatorrhoea. Option: D. Pancreatic pseudocyst is defined as a localized collection of pancreatic secretions, usually rich in digestive enzymes, that is enclosed by a non-epithelialized wall and persists for more than 4 weeks. Treatment is either conservative or drainage of the pseudocyst.</p>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "2cf4e048",
      "audio": ""
    }
  ]
}